prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumA, page 1 / 2. copy No. Examination: Intraoperative examination. Cost of diagnostic procedure. Gender: F. Material: Lesion resection - from the left breast with - outer quad. boundary. Expected time of examination: 20 minutes (from receipt of the material). Clinical diagnosis: Cancer of the left breast,/Cancer of the left breast. Lesion on the boundary of outer quadrants. Marked. typically. Please evaluate the margins. Results of immunohistochemical examination: Part of the breast sized 9 x 7 x 4 cm with a skin flap of 5 x 1.5 cm. Margins: 1.3 cm to the base, 1.6 cm to the skin, 2.5 cm to the. sternum, 2.5 cm to the axilla, 3 cm to the shoulder, 2 cm to the lower boundary. Result of intraoperative examination: Carcinoma invasivum. Macroscopic description: Part of the breast sized 9 x 7 x 4 cm with a skin flap of 5 x 1.5 cm. Margins: 1.3 cm to the base, 1.6 cm to the skin, 2.5 cm to the. sternum, 2.5 cm to the axilla, 3 cm to the shoulder, 2 cm to the lower boundary. Microscopic description: Carcinoma ductale invasivum - NHG2 (3+2+1/5 mitoses/10 HPF - visual area 0.55mm). Additionally, benign lesions of the type adenosis sclerosans et "blunt duet" and lymph node free of neoplastic. metastasis. Margins as in the macroscopic description. Histopathological diagnosis: Carcinoma ductale invasivum mammae sinistrae. (NHG2, pTIc, pNO /sn/). Invasive ductal carcinoma of the left breast. (NHG2, pTIc, pNO /sn/). Examination: Intraoperative examination. page 2 / 2. Gender: F. Result of immunohistochemical test: Estrogen receptors found in over 75% of neoplastic cell nuclei. Progesterone receptors found in over 75% of. neoplastic cell nuclei. HER2 protein stained with HercepTest™M by DAKO. Negative reaction in invasive carcinoma. cells ( Score = 1+ 1.

expanded version (tokens=935) : 
 Based on the breast pathology report, the following information can be extracted:

1. Histological Classification: The patient has invasive ductal carcinoma of the left breast. The subtype is LumA, which is a type of breast cancer that usually has a good prognosis.

2. Necrosis: There is no mention of necrosis in the report.

3. Tumor Infiltrating Lymphocytes: There is no mention of tumor infiltrating lymphocytes in the report.

4. Histological Grade: The histological grade of the tumor is NHG2 (3+2+1/5 mitoses/10 HPF - visual area 0.55mm). This means the tumor is moderately differentiated.

5. Nuclear Grade: The nuclear grade of the tumor is NHG2.

6. Lymphovascular Invasion: There is no mention of lymphovascular invasion in the report.

7. Calcification: There is no mention of calcification in the report.

8. Receptor Status: The patient's tumor is positive for estrogen receptors found in over 75% of neoplastic cell nuclei and progesterone receptors found in over 75% of neoplastic cell nuclei. The HER2 protein stained with HercepTest™M by DAKO is negatively expressed.

9. IHC testing results: The HER2 protein stained with HercepTest™M by DAKO is negatively expressed with a score of 1+1.

10. Ancillary testing results: There

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1092) : 
 A female patient has LumA subtype invasive ductal carcinoma of the left breast without necrosis or lymphovascular invasion. Histological grade is NHG2. Nuclear grade is NHG2. Estrogen and progesterone receptors are positive, while HER2 protein expression is negative. No calcification or tumor infiltrating lymphocytes were found upon examination. Ancillary tests indicated a score of 1+1 for the HER2 protein expression test. The patient also has benign lesions of adenosis sclerosans et "blunt duet".

